ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 25 filers reported holding ANI PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $20,140,000 | -9.1% | 18,779,000 | 0.0% | 2.44% | -2.6% |
| Q2 2019 | $22,147,000 | +7.4% | 18,779,000 | 0.0% | 2.50% | -9.2% |
| Q1 2019 | $20,614,000 | +9.4% | 18,779,000 | 0.0% | 2.76% | +9.8% |
| Q4 2018 | $18,849,000 | -5.3% | 18,779,000 | 0.0% | 2.51% | +100.2% |
| Q3 2018 | $19,906,000 | -7.2% | 18,779,000 | +99900.0% | 1.25% | -9.2% |
| Q2 2018 | $21,455,000 | +3.7% | 18,779 | 0.0% | 1.38% | +2.4% |
| Q1 2018 | $20,692,000 | -3.9% | 18,779 | 0.0% | 1.35% | -53.6% |
| Q4 2017 | $21,537,000 | +6.0% | 18,779 | 0.0% | 2.90% | -16.5% |
| Q3 2017 | $20,315,000 | +2.5% | 18,779 | 0.0% | 3.48% | -13.9% |
| Q2 2017 | $19,817,000 | +300.7% | 18,779 | +302.1% | 4.04% | +257.3% |
| Q1 2017 | $4,946,000 | – | 4,670 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 46,542 | $43,298,000 | 2.53% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $7,370,000 | 0.75% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,500,000 | $1,388,000 | 0.60% |
| Perceptive Advisors | 15,000,000 | $13,846,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 15,211,000 | $14,296,000 | 0.34% |
| LINDEN ADVISORS LP | 3,500,000 | $3,258,000 | 0.22% |
| Visium Asset Management, LP | 6,500,000 | $6,067,000 | 0.08% |
| ZAZOVE ASSOCIATES LLC | 1,750,000 | $1,625,000 | 0.08% |
| Investors Capital Advisory Services | 326,000 | $300,000 | 0.06% |
| LAZARD ASSET MANAGEMENT LLC | 15,969,000 | $14,771,000 | 0.04% |